Brookfield Asset Management just delivered its Q1 results on May 8, and the market response was immediate. The stock added 2% on earnings day and finished the week up more than 4%, hitting CAD 68.01 — a continuation of an 11% run over the past month.
The quarter's headline was the CEO's characterisation of AI as a "significant tailwind." That framing matters for BAM's long-term positioning: the firm has been aggressively building out data centre and digital infrastructure capacity, and AI-driven power demand directly feeds the case for Brookfield's infrastructure asset base. The May 4 announcement of a collaboration with The Nuclear Company around Westinghouse reactor technology reinforced that narrative — demand for always-on, carbon-light power is real, and BAM is planting flags ahead of that wave.
Positioning in the lending market carried an interesting footnote into the print. Cost to borrow spiked sharply on May 5 to 1.27%, a level that drew attention — borrow availability tightened as some traders scrambled to establish short positions ahead of results. That spike proved short-lived; CTB has since eased back to around 0.62%. With short interest only 0.55% of free float and the borrow market now relatively relaxed — availability is not under any structural stress — there was no meaningful short pressure heading into or out of earnings. The ORTEX short score of 36 sits in the low-to-middle range of its recent history, and utilisation has edged up from roughly 6.5% in late March to around 14% now, though that still leaves the lending pool far from tight. This is not a crowded short.
The Street's reaction has been mixed rather than celebratory. JPMorgan maintained its Neutral on BAM on May 6 and cut its price target to USD 60. Morgan Stanley held at Equal-Weight on April 21 and trimmed to USD 62. Both moves suggest the large Wall Street houses are not yet willing to chase the rally — they see the AI tailwind narrative as credible but are cautious on valuation. The stock is trading at a P/E of around 25x and a price-to-book of just above 8x, with EV/EBITDA near 19x. The P/B multiple has expanded by roughly 0.37x over the past month alone, tracking the price run. That re-rating pace is precisely what has JPMorgan and Morgan Stanley sitting on their hands. The dividend score ranks in the 93rd percentile, making BAM's income profile one of the strongest in its peer universe — a genuine differentiator for yield-seeking institutional buyers.
Peer performance this week adds context. Close correlate BN — the parent company, with an 86% correlation — added 4.7% on the week, almost perfectly tracking BAM. Alternatives managers ARES and OWL gained 6.1% and 5.8% respectively, suggesting the move is as much a sector re-rating as a stock-specific story. BX and KKR lagged, finishing the week down 2% and down 1.1% — a divergence worth noting, since those two names are more directly exposed to M&A cycle timing. BAM's infrastructure and real assets orientation may be attracting a different buyer base than pure-play private equity.
On ownership, the structure is unusual: Brookfield Corporation itself holds 74% of shares outstanding, leaving a thin public float. That concentration is a permanent feature of the stock's mechanics, not a new development, but it helps explain why short interest is so low and why the lending market can spike on modest borrow demand. Principal Global Investors added nearly 4.9 million shares in the most recent quarter, the largest incremental buy among the institutional holders listed, while Fidelity International trimmed by about 3 million shares. The pattern is broadly one of value-oriented buyers adding and some international holders lightening.
What to watch now: with the quarterly print behind it and no next earnings date yet confirmed, the focus shifts to whether the AI and nuclear infrastructure narrative continues to attract capital flows into the alternatives sector — and whether JPMorgan's USD 60 target cap begins to act as a ceiling on a stock that currently trades roughly 13% above it in USD terms.
See the live data behind this article on ORTEX.
Open BAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.